Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
14.16
-0.43 (-2.95%)
Apr 29, 2026, 12:24 PM EDT - Market open
Olema Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 48.3 | 139.48 | 68.54 | 23.7 | 13.81 | Upgrade
|
| Short-Term Investments | 457.14 | 294.61 | 193.27 | 180.72 | 273.44 | Upgrade
|
| Cash & Short-Term Investments | 505.44 | 434.09 | 261.81 | 204.42 | 287.25 | Upgrade
|
| Cash Growth | 16.44% | 65.80% | 28.07% | -28.84% | -15.15% | Upgrade
|
| Other Receivables | 4.06 | 2.12 | 0.67 | 0.32 | 0.13 | Upgrade
|
| Receivables | 4.06 | 2.12 | 0.67 | 0.32 | 0.13 | Upgrade
|
| Prepaid Expenses | 4.37 | 1.9 | 2.35 | 2.64 | 2.97 | Upgrade
|
| Other Current Assets | 1.59 | 0.37 | 1.68 | 1.52 | 0.33 | Upgrade
|
| Total Current Assets | 515.45 | 438.47 | 266.51 | 208.9 | 290.69 | Upgrade
|
| Property, Plant & Equipment | 1.42 | 2.06 | 3.26 | 2.5 | 4.72 | Upgrade
|
| Long-Term Deferred Charges | 0.89 | 0.68 | - | - | - | Upgrade
|
| Other Long-Term Assets | 15.67 | 9.76 | 7.17 | 4.25 | 0.54 | Upgrade
|
| Total Assets | 533.43 | 450.98 | 276.95 | 215.65 | 295.95 | Upgrade
|
| Accounts Payable | 9.25 | 4.46 | 2.7 | 0.37 | 0.02 | Upgrade
|
| Accrued Expenses | 41.43 | 36.13 | 17.86 | 15.09 | 7.81 | Upgrade
|
| Current Portion of Leases | 1.12 | 1.17 | 0.99 | 1.02 | 0.93 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.07 | 0.07 | 0.09 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.17 | Upgrade
|
| Total Current Liabilities | 51.8 | 41.76 | 21.62 | 16.55 | 9.02 | Upgrade
|
| Long-Term Debt | 3 | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.07 | 0.26 | 1.43 | 1.55 | 2.36 | Upgrade
|
| Total Liabilities | 54.87 | 42.02 | 23.05 | 18.1 | 11.38 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,075 | 843.92 | 559.18 | 408.33 | 388.9 | Upgrade
|
| Retained Earnings | -597.56 | -435.11 | -305.63 | -208.98 | -104.19 | Upgrade
|
| Comprehensive Income & Other | 0.62 | 0.14 | 0.35 | -1.81 | -0.15 | Upgrade
|
| Total Common Equity | 478.56 | 408.96 | 253.9 | 197.55 | 284.57 | Upgrade
|
| Shareholders' Equity | 478.56 | 408.96 | 253.9 | 197.55 | 284.57 | Upgrade
|
| Total Liabilities & Equity | 533.43 | 450.98 | 276.95 | 215.65 | 295.95 | Upgrade
|
| Total Debt | 4.19 | 1.43 | 2.42 | 2.57 | 3.29 | Upgrade
|
| Net Cash (Debt) | 501.24 | 432.66 | 259.39 | 201.86 | 283.96 | Upgrade
|
| Net Cash Growth | 15.85% | 66.80% | 28.50% | -28.91% | -16.12% | Upgrade
|
| Net Cash Per Share | 5.76 | 7.37 | 5.73 | 5.05 | 7.18 | Upgrade
|
| Filing Date Shares Outstanding | 87.16 | 68.33 | 55.91 | 40.63 | 39.85 | Upgrade
|
| Total Common Shares Outstanding | 81.38 | 74.31 | 54.99 | 40.29 | 39.84 | Upgrade
|
| Working Capital | 463.65 | 396.72 | 244.89 | 192.35 | 281.67 | Upgrade
|
| Book Value Per Share | 5.88 | 5.50 | 4.62 | 4.90 | 7.14 | Upgrade
|
| Tangible Book Value | 478.56 | 408.96 | 253.9 | 197.55 | 284.57 | Upgrade
|
| Tangible Book Value Per Share | 5.88 | 5.50 | 4.62 | 4.90 | 7.14 | Upgrade
|
| Machinery | - | - | - | - | 1.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.